Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
Sinovac Biotech Total Liabilities (Quarterly): 1.390B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.390B |
| June 30, 2024 | 1.390B |
| December 31, 2023 | 1.635B |
| June 30, 2023 | 1.488B |
| June 30, 2023 | 1.488B |
| December 31, 2022 | 1.402B |
| June 30, 2022 | 971.93M |
| December 31, 2021 | 2.872B |
| June 30, 2021 | 3.498B |
| December 31, 2020 | 781.20M |
| September 30, 2020 | 281.31M |
| June 30, 2020 | 191.38M |
| March 31, 2020 | 93.83M |
| December 31, 2019 | 100.10M |
| September 30, 2019 | 96.98M |
| June 30, 2019 | 92.04M |
| March 31, 2019 | 81.56M |
| December 31, 2018 | 77.85M |
| June 30, 2018 | 110.54M |
| December 31, 2017 | 122.08M |
| June 30, 2017 | 95.87M |
| December 31, 2016 | 81.69M |
| September 30, 2016 | 76.12M |
| June 30, 2016 | 58.00M |
| March 31, 2016 | 66.12M |
| Date | Value |
|---|---|
| December 31, 2015 | 66.42M |
| September 30, 2015 | 65.55M |
| June 30, 2015 | 74.49M |
| March 31, 2015 | 73.12M |
| December 31, 2014 | 96.80M |
| September 30, 2014 | 102.05M |
| June 30, 2014 | 91.48M |
| March 31, 2014 | 96.20M |
| December 31, 2013 | 97.05M |
| September 30, 2013 | 91.19M |
| June 30, 2013 | 91.73M |
| March 31, 2013 | 88.22M |
| December 31, 2012 | 79.33M |
| September 30, 2012 | 75.58M |
| June 30, 2012 | 73.78M |
| March 31, 2012 | 71.01M |
| December 31, 2011 | 70.61M |
| September 30, 2011 | 66.29M |
| June 30, 2011 | 59.35M |
| March 31, 2011 | 63.98M |
| December 31, 2010 | 66.60M |
| September 30, 2010 | 52.67M |
| June 30, 2010 | 43.30M |
| March 31, 2010 | 59.20M |
| December 31, 2009 | 61.01M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
93.83M
Minimum
Mar 2020
3.498B
Maximum
Jun 2021
1.256B
Average
1.390B
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | 42.25M |
| Zai Lab Ltd | 283.19M |
| China SXT Pharmaceuticals Inc | 9.197M |
| Adagene Inc | 44.19M |
| LakeShore Biopharma Co Ltd | 144.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.90B |
| Shareholders Equity (Quarterly) | 8.649B |
| Debt to Equity Ratio | 0.0358 |
| Current Ratio | 11.39 |
| Net Debt Paydown Yield | -21.04% |